MAIA Biotechnology Inc (MAIA)

개요 뉴스 가격 이력 토론 예측

MAIA Biotechnology Inc 주식(MAIA)의 최신 뉴스

MAIA Biotechnology Inc (MAIA)

MAIA Biotechnology Inc 주식(MAIA)의 최신 뉴스

MAIA Biotechnology, Inc. to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients - Marketscreener.com

Maia Biotechnology Plans to Begin Phase 3 Lung Cancer Trial of THIO-104 in H2 -February 27, 2025 at 10:58 am EST - Marketscreener.com

MAIA Biotechnology to initiate THIO-104 trial - TipRanks

Can MAIA's THIO Outperform Chemotherapy in Advanced Lung Cancer? Phase 3 Trial Will Decide - StockTitan

MAIA Biotechnology Secures $1.43 Million in Non-Brokered Private Placement - Defense World

MAIA Biotech announces trial design to expand THIO-101 Phase 2 NSCLC study - TipRanks

MAIAMAIA Biotechnology Inc. Latest Stock News & Market Updates - StockTitan

MAIA Biotechnology expands phase 2 cancer trial - Investing.com

Can This Lung Cancer Treatment's 16.9-Month Survival Rate Transform Third-Line Therapy? - StockTitan

Maia Biotechnology director Stan Smith acquires $75,000 in stock - Investing.com India

Maia Biotechnology director Stan Smith acquires $75,000 in stock By Investing.com - Investing.com South Africa

MAIA Biotechnology announces non-brokered private placement of $1.43M - MSN

MAIA Biotechnology Announces Non-Brokered Private Placement of Approximately $1.43 Million - BioSpace

Can This $4.1M Funding Push MAIA's Cancer Drug Trial to the Next Level? - StockTitan

MAIA Biotechnology announces $2.7M private placement - MSN

MAIA Biotechnology, Inc. announced that it expects to receive $2.715 million in funding -February 17, 2025 - Marketscreener.com

MAIA Biotechnology Announces Private Placement of $2,715,000 - BioSpace

MAIA Biotechnology secures $2.7 million in private placement - Investing.com India

MAIA Biotechnology secures $2.7 million in private placement By Investing.com - Investing.com South Africa

MAIA Biotechnology to sell 1.81M shares at $1.50 in private placement - TipRanks

MAIA Biotech Raises Strategic $2.7M with Insider Backing for Crucial Phase II Cancer Trial - StockTitan

MAIA Biotechnology announces updated data from THIO-101 trial - MSN

MAIA Biotech executives receive salary hikes and new terms - MSN

MAIA Biotech executives receive salary hikes and new terms By Investing.com - Investing.com South Africa

MAIA Biotechnology Announces Efficacy Updates for THIO-101 Trial in Advanced Non-Small Cell Lung Cancer - Defense World

MAIA Biotechnology Amends Employment Agreements with Executive Officers - Defense World

MAIA Biotechnology Updates Executive Compensation Packages - TipRanks

MAIA Biotechnology Inc (MAIA) can make a big difference with a little luck - SETE News

Investing in MAIA Biotechnology Inc (MAIA) Is Getting More Attractive - Knox Daily

MAIA Biotechnology Reports Promising Phase 2 Trial Results - TipRanks

MAIA Biotechnology reports promising THIO trial results for NSCLC By Investing.com - Investing.com South Africa

MAIA Stock on the Rise: A Promising Investment - The InvestChronicle

Breaking down MAIA’s current quarter earnings estimates - US Post News

MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer - BioSpace

MAIA Biotechnology reports promising THIO trial results for NSCLC - Investing.com India

MAIA Biotechnology, Inc. Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer - Marketscreener.com

MAIA Biotechnology (NYSEAMERICAN:MAIA) Trading 0.5% Higher – What’s Next? - Defense World

Atara to cut 50% of workforce amid FDA woes (ATRA:NASDAQ) - Seeking Alpha

MAIA Biotechnology, BeiGene announce clinical supply agreement - The Cancer Letter

When Will MAIA Biotechnology Inc (AMEX: MAIA) Be A Good Investment? - Marketing Sentinel

Geode Capital Management LLC Grows Position in MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) - Defense World

MAIA Biotech to Present THIO Cancer Treatment Pipeline at Biotech Showcase 2025 - StockTitan

MAIA Biotechnology Shares Rise After Supply Agreement With BeiGene - MarketWatch

MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications - BioSpace

MAIA Biotech partners with BeiGene for cancer trials - Investing.com

MAIA Biotechnology Directors Show Strong Confidence with $573K Personal Investment in Private Placement - StockTitan

MAIA과 유사한 종목